Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Hunter

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
Primary radiation therapy for endometrial carcinoma: a case controlled studyP G Rose, S Baker, M Kern, et al.
Cancer Research|November 15, 1987
Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibodyD J Hnatowich, M Gionet, M Rusckowski, et al.
Cancer|December 15, 1983
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyT W Griffin, A E Bogden, S D Reich, et al.
Cancer|November 1, 1991
High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancerR E Hunter, T W Griffin, S Stevens, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
Primary radiation therapy for endometrial carcinoma: a case controlled studyP G Rose, S Baker, M Kern, et al.
Cancer Research|November 15, 1987
Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibodyD J Hnatowich, M Gionet, M Rusckowski, et al.
Cancer|December 15, 1983
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapyT W Griffin, A E Bogden, S D Reich, et al.
Cancer|November 1, 1991
High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancerR E Hunter, T W Griffin, S Stevens, et al.
Pageof 8